ClinicalTrials.Veeva

Menu

Northern Colorado COVID-19 Biobank (NoCo-CoBio)

Colorado State University (CSU) logo

Colorado State University (CSU)

Status

Completed

Conditions

Covid19

Study type

Observational

Funder types

Other

Identifiers

NCT04603677
20-10063H

Details and patient eligibility

About

The NoCo-CoBio Project is a biobanking effort to store and preserve saliva, nasopharyngeal, stool and blood specimens from SARS-CoV-2 PCR (polymerase chain reaction) positive individuals.

Full description

The investigators have created a biorepository of stool, saliva, nasopharyngeal swab specimens, peripheral blood mononuclear cells, serum, and plasma from SARS-CoV-2 infected individuals for research purposes. The multifaceted biorepository will be used to establish markers predicting various presentations of COVID-19 (coronavirus disease 2019).

Enrollment

148 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Those who have had a positive SARS-CoV-2 PCR test

Exclusion criteria

  • under 18 years of age
  • pregnant

Trial design

148 participants in 2 patient groups

Acute phase of SARS-CoV-2 infection
Description:
Participants with an acute SARS-CoV-2 infection. Intervention will not be implemented in this study.
Convalescent phase of SARS-CoV-2 infection
Description:
Participants with a previous diagnosis of SARS-CoV-2 infection, now in the convalescent phase of disease. Intervention will not be implemented in this study.

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems